Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 10, pp. 3012-3024
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 9, 2001
- Revision received July 2, 2001
- Accepted July 3, 2001
- Published first October 1, 2001.
Copyright & Usage
© 2001
Author Information
- Craig L. Slingluff Jr.2,
- Galina Yamshchikov,
- Patrice Neese,
- Holly Galavotti,
- Shannon Eastham,
- Victor H. Engelhard,
- Dave Kittlesen3,
- Donna Deacon,
- Sarah Hibbitts,
- William W. Grosh,
- Gina Petroni,
- Roger Cohen,
- Catie Wiernasz,
- James W. Patterson,
- Brian P. Conway, and
- William G. Ross
- Departments of Surgery [C. L. S., G. Y., P. N., H. G., S. E., D. K., D. D., S. H.], Medicine [W. W. G., R. C.], Health Evaluation Sciences [G. P.], Microbiology and Beirne Carter Center for Immunology Research [V. H. E.], Cancer Center Clinical Trials Office [C. W.], Pathology [J. W. P.], Ophthalmology [B. P. C.], and Cancer Center FACS Core Facility [W. G. R.], University of Virginia, Charlottesville, Virginia 22906
October 2001
Volume 7, Issue 10
Volume 7, Issue 10
Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant
Jump to section
Advertisement